Efficacy and safety of retreatment with Elbasvir/Grazoprevir associated to Sofosbuvir plus /- Ribavirin in HCV infected patients with a previous failure to therapy with direct-acting antiviral drugs

被引：0
|
作者：
Alric, Laurent [1 ]
Leroy, Vincent [2 ]
Cotte, Laurent [3 ]
Anne, Minello [4 ]
Remy, Andre Jean [5 ]
Rouanet, Isabelle [6 ]
Godart, Marion [1 ]
Hezode, Christophe [7 ]
Abravanel, Florence [8 ]
Ollivier-Hourmand, Isabelle [9 ]
机构：
[1] CHU Purpan, Internal Med Digest Dept, Toulouse, France
[2] CHU, Digest Dept, Grenoble, France
[3] Hop Lyon, Digest Dept, Lyon, France
[4] CHU, Digest Dept, Dijon, France
[5] Hop Perpignan, Digest Dept, Perpignan, France
[6] CHU, Digest Dept, Nimes, France
[7] CHU Henri Mondor, Digest Dept, Creteil, France
[8] CHU Purpan, Virol, Toulouse, France
[9] CHU, Digest Dept, Caen, France
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1544
引用
收藏
页码：824A / 825A
页数：2
相关论文
共 50 条
  • [1] Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
    Forns, Xavier
    Gordon, Stuart C.
    Zuckerman, Eli
    Lawitz, Eric
    Calleja, Jose L.
    Hofer, Harald
    Gilbert, Christopher
    Palcza, John
    Howe, Anita Y. M.
    DiNubile, Mark J.
    Robertson, Michael N.
    Wahl, Janice
    Barr, Eliav
    Buti, Maria
    JOURNAL OF HEPATOLOGY, 2015, 63 (03) : 564 - 572
  • [2] Successful Retreatment of HCV Genotype-1 Infected Patients Who Failed Prior Therapy With Peginterferon plus Ribavirin Plus 1 or 2 Other Direct-Acting Antiviral Agents With Sofosbuvir
    Jacobson, Ira M.
    Sulkowski, Mark
    Hassanein, Tarek
    Ni, Liyun
    Mo, Hongmei
    Kanwar, Bittoo
    Brainard, Diana M.
    Subramanian, G. M.
    Symonds, William T.
    McHutchison, John G.
    Bennett, Michael T.
    Gane, Edward
    GASTROENTEROLOGY, 2014, 146 (05) : S904 - S904
  • [3] SUCCESSFUL RETREATMENT WITH SOFOSBUVIR OF HCV GENOTYPE-1 INFECTED PATIENTS WHO FAILED PRIOR THERAPY WITH PEGINTERFERON plus RIBAVIRIN PLUS 1 OR 2 ADDITIONAL DIRECT-ACTING ANTIVIRAL AGENTS
    Pol, S.
    Sulkowski, M.
    Hassanein, T.
    Gane, E.
    Liyun, N.
    Ho, H.
    Kanwar, B.
    Brainard, D.
    Subramanian, M.
    Symonds, W. T.
    McHutchison, J. G.
    Bennett, M.
    Jacobson, I. M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S23 - S23
  • [4] Efficacy of Elbasvir-Grazoprevir/Sofosbuvir and Ribavirin in direct acting antiviral therapy failures in pre and post liver transplant patients: A single center experience
    Elbeshbeshy, H.
    Hasan, H.
    Salih, I.
    Elsiesy, H.
    Alhamoudi, W.
    Alkhail, F. A.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S295 - S296
  • [5] Effect of Resistance Associated Substitutions on Retreatment of HCV infected patients with prior failure to Direct Acting Antiviral Therapy
    Smith, David
    Bradshaw, Daniel
    Mbisa, Jean
    Manso, Carmen
    Bibby, David
    Singer, Josh
    Thomson, Emma
    Filipe, Ana
    Aranday-Cortes, Elihu
    Ansari, Azim
    Brown, Anthony
    Hudson, Emma
    Benselin, Jennifer
    Healy, Brendan
    Mclauchlan, John
    Barnes, Eleanor
    Irving, William
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E158 - E159
  • [6] Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in postliver transplant patients with previous direct-acting antiviral failure: Six case reports
    Cory Higley
    Christine C Hsu
    Coleman Smith
    Sandeep Nadella
    Alexander T.Lalos
    World Journal of Hepatology, 2020, 12 (12) : 1341 - 1348
  • [7] Salvage therapy with sofosbuvir, elbasvir, grazoprevir, and ribavirin for direct-acting antiviral non-responders: High efficacy in genotype 1/4 and genotype 3 hepatitis C virus infection
    Papaluca, T.
    Glasgow, S.
    Nate, K.
    Craigie, A.
    Mcdonald, L.
    Stothers, L.
    Iser, D.
    Desmond, P.
    Bell, S.
    Demediuk, B.
    Visvanathan, K.
    Ryan, M.
    Howell, J.
    Hong, T.
    Croagh, C.
    Sinclair, M.
    Arachchi, N.
    Thompson, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 62 - 63
  • [8] Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Patients With Previous Direct-Acting Antiviral Therapy Failures: A Meta-Analysis
    Shen, Chao
    Fan, Haozhi
    Ge, Zhijun
    Cai, Weihua
    Shao, Jianguo
    Dong, Chen
    Xue, Hong
    Fu, Zuqiang
    Li, Jun
    Zhang, Yun
    Yue, Ming
    FRONTIERS IN MEDICINE, 2020, 7
  • [9] Real-world retreatment of HCV-infected patients with prior failure to direct acting antiviral therapy using sofosbuvir, velpatasvir and voxilaprevir
    Smith, David A.
    Bradshaw, Daniel
    Mbisa, Jean
    Manso, Carmen
    Bibby, David
    Singer, Josh
    Thomson, Emma
    Filipe, Anna da Silva
    Aranday-Cortes, Elihu
    Ansari, Azim
    Brown, Anthony
    Hudson, Emma
    Benselin, Jennifer
    Healy, Brendan
    Troke, Phil
    Mclauchlan, John
    Barnes, Eleanor
    Irving, William
    JOURNAL OF HEPATOLOGY, 2020, 73 : S336 - S336
  • [10] Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
    Higley, Cory
    Hsu, Christine C.
    Smith, Coleman
    Nadella, Sandeep
    Lalos, Alexander T.
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (12) : 1341 - 1348
12345